Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study. - Trial NCT06356948
Access comprehensive clinical trial information for NCT06356948 through Pure Global AI's free database. This Phase 4 trial is sponsored by University of British Columbia and is currently Recruiting. The study focuses on Healthy Participants. Target enrollment is 110 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of British Columbia
Timeline & Enrollment
Phase 4
Mar 30, 2024
Dec 30, 2027
Primary Outcome
Change in systolic blood pressure from baseline over 15 minutes post-TXA administration between groups.
Summary
Tranexamic acid is a well-established treatment for post-partum hemorrhage. This study aims
 to examine the effect of tranexamic acid administration rates on blood pressure changes over
 1 minute compared to 10 minutes in healthy pregnant patients scheduled for cesarean delivery.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06356948
Non-Device Trial